Zydus Cadila has sought regulatory approval for clinical trials of its antibody cocktail to treat mild COVID-19, as India grapples with a shortage of medicines and vaccines needed to effectively...
from NDTV News - Latest https://ift.tt/3yAhyIu
via IFTTT
from NDTV News - Latest https://ift.tt/3yAhyIu
via IFTTT
Advertisement
